DUBLIN–(BUSINESS WIRE)–The “Global Biosimilars Market, By Indication Type, By Product & By Region- Forecast and Analysis 2022-2028” report has been added to ResearchAndMarkets.com’s offering. Global Biosimilars Market is valued at $15.2 billion in 2021 and is projected to attain a value of $68.95 billion by 2028 at a CAGR of 24.2% during the forecast period, … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Single-use Flexible Endoscope Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. The single-use endoscope is a breakthrough technology that is revolutionizing the global endoscopy space to eliminate the risk of cross-contamination among patients. Despite compliance with manufacturers’ instructions, multiple outbreaks from contaminated reusable endoscopes (specifically, duodenoscopes and bronchoscopes) continue to occur. … [Read more…]
LONDON–(BUSINESS WIRE)–True, the premiere global platform of innovative talent management products and services, announced today the appointment of EMEA and APAC leaders for True Search’s Climate Tech practice and Healthcare & Life Sciences practices. Partner Nathaniel Hook, formerly managing director of global executive search firm WittKieffer, is now Head of Healthcare & Life Sciences practices, … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Pruritus Therapeutics Market By Drug type, By Disease Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering. The global pruritus therapeutics market was valued at $7,849.4 million in 2021, and is projected to reach $11,186.15 million by 2031, registering a CAGR of 3.6% from … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants), By Regional Outlook and Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Global Narcolepsy Therapeutics Market size is expected to reach $5 … [Read more…]
Rahko’s Co-founder and former VP of AI at Odyssey Therapeutics will lead the technical growth of LabGenius’ ML-driven drug discovery platform LONDON–(BUSINESS WIRE)–#AI–LabGenius, a pioneer in the use of machine learning (ML) for antibody-based drug discovery, today announced the appointment of Leonard Wossnig Ph.D. as Chief Technology Officer (CTO). In this role, Leonard will lead … [Read more…]
Curapath will develop and optimize a process to produce a nanoparticle formulation for the vaccine VALENCIA, Spain & BOSTON–(BUSINESS WIRE)–Curapath, a leader in the design, development, and custom manufacturing of polyamino-acid- and lipid-based nanoparticle delivery systems for therapeutics and vaccines, today announced a collaboration with Afrigen Biologics to advance the development of the first African-owned … [Read more…]
TOKYO–(BUSINESS WIRE)–PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President & CEO: Shoji Miyazaki, hereafter PHC Group) announces the release of its newly revised Mid-term Plan, the “Value Creation Plan”*1 for FY2022 to FY2025. The primary update in this plan is the introduction of new business growth areas that will enable PHC Group to advance value-based … [Read more…]
Expression of the pathogenic W-ENV protein triggered by the SARS-CoV-2 infection, continuing long after the acute phase has been resolved, is suspected to have a major role in the persistence of inflammation in many long-COVID patients. The personalized medicine trial will evaluate temelimab, the anti-W-ENV antibody developed by GeNeuro, as a Disease Modifying Therapy in … [Read more…]
BEIJING & BURLINGTON, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization of transformative therapies to treat rare diseases and oncology, announced that CAN106, a clinical-stage recombinant humanized monoclonal antibody targeting C5, has been granted Orphan Drug Designation by the United States Food … [Read more…]
